Advertisement

Athena Diagnostics, a former Worcester business unit of Thermo Fisher Scientific Inc., has finalized its $740 million sale to Quest Diagnostics Inc. (NYSE: DGX) today.

A news release from New Jersey diagnostic testing giant Quest indicated that Athena would continue to operate in its Worcester facility under its own name as an independent neurology diagnostics business of Quest.

SOURCE

Advertisement
Advertisement